Clinical Trial Update: Niraparib Combined With Radiotherapy in rGBM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating niraparib combined with radiotherapy for recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Tianjin Huanhu Hospital | Conditions: Recurrent Glioblastoma | Phase 2 | Status: UNKNOWN